Meysami, Parisa, Rezaei, Farhad, Marashi, Sayed Mahdi, Amiri, Mohammad Mehdi, Bakker, Emyr ORCID: 0000-0002-0091-1029 and Mokhtari-Azad, Talat
(2019)
Antitumor effects of a recombinant baculovirus displaying anti-HER2 scFv expressing Apoptin in HER2 positive SK-BR-3 breast cancer cells.
Future Virology, 14
(3).
ISSN 1746-0794
Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr ORCID: 0000-0002-0091-1029, Demonacos, Constantinos, Giordano, Antonio, Krstic-Demonacos, Marija and Mutti, Luciano
(2019)
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment.
International Journal of Molecular Sciences, 20
(2).
ISSN 1661-6596
Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr ORCID: 0000-0002-0091-1029, Bonanni, Ezio, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano
(2019)
What can independent research for mesothelioma achieve to treat this orphan disease?
Expert Opinion on Investigational Drugs, 28
(8).
pp. 719-732.
ISSN 1354-3784
Tian, Kun, Bakker, Emyr ORCID: 0000-0002-0091-1029, Hussain, Michelle, Guazzelli, Alice, Alhebshi, Hasen, Meysami, Parisa, Demonacos, Constantinos, Schwartz, Jean-Marc, Mutti, Luciano et al
(2018)
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.
Journal of Translational Medicine, 16
.
p. 282.